The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyFriday, August 9, 2024Availability, Economic impact/cost-effectivenssRead More
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countriesFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Potential implementation strategies, acceptability, and feasibility of new and repurposed TB vaccinesFriday, August 9, 2024Accessibility, Implementation strategies and feasibilityRead More
TB vaccine market analysisFriday, August 9, 2024Accessibility, Availability, Economic impact/cost-effectivenss, Economic impact/cost-effectivenss, FInancing strategies, FInancing strategiesRead More
Cost-effectiveness of routine adolescent vaccination with an M72/AS01E-like tuberculosis vaccine in South Africa and India.Tuesday, July 16, 2024Available, demand assessedRead More
The Health and Economic Benefits Possible with Novel Tuberculosis Vaccines – A Modeling Study in India and Indonesia.Tuesday, July 16, 2024Available, demand assessedRead More
